<DOC>
	<DOCNO>NCT00262054</DOCNO>
	<brief_summary>The purpose study determine whether bivalirudin give PCI associate well outcome compare un-fractionated heparin .</brief_summary>
	<brief_title>Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions ( PCI ) ( ISAR-REACT-3 )</brief_title>
	<detailed_description>Thrombin play major role acute coronary artery occlusion percutaneous coronary intervention . Unfractionated heparin traditionally use invasive coronary procedure reduce risk thrombotic occlusion . Bivalirudin , direct antithrombin inhibitor , several advantage unfractionated heparin : act independently antithrombin inhibits free clot-bound thrombin ; neutralize circulating inhibitor ; exhibit consistent dose-response characteristic , cause thrombocytopenia . Previous study show use bivalirudin among patient undergo percutaneous coronary intervention associate well outcome ( death , myocardial infarction , urgent repeat revascularization in-hospital major bleed ) compare unfractionated heparin adjunctive use glycoprotein IIb/IIIa platelet receptor inhibitor . However , previous study include patient treat plain balloon angioplasty stenting inadequate pre-treatment thienopyridines ( ticlopidine clopidogrel ) . Recent guideline recommend patient undergo percutaneous coronary intervention must receive load dose 300 -600 mg clopidogrel . A 600 mg load dose clopidogrel eliminates need glycoprotein IIb/IIIa platelet receptor inhibitor adjunct heparin . According exist evidence antithrombotic regimen base either bivalirudin pre-treatment 600 mg clopidogrel addition UFH intraprocedurally , effective strategy reduce ischemic hemorrhagic complication patient coronary artery disease undergo PCI . At present , know whether bivalirudin superior UHF patient optimally pre-treated load dose clopidogrel .</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Patients older 18 year age undergo PCI Clopidogrel load least 2 hrs prior PCI accord PCI guideline Informed , write consent Recent STelevation myocardial infarction within last 48 hour Cardiogenic shock ACS positive biomarkers ( Troponin T &gt; 0.03 Âµg/L ) Malignancies comorbid condition ( example severe liver , renal pancreatic disease ) life expectancy le one year may result protocol noncompliance Active bleeding ; bleed diathesis History gastrointestinal genitourinary bleeding within last 6 week Presence disease high probability vascular lesion subsequent bleed active gastric ulcer active ulcerous colitis Recent trauma major surgery last month Ophthalmic surgery brain surgery last month Retinopathies vitreous body bleed last month History intracranial bleed structural abnormality ( example aneurysm cerebral artery ) Suspected aortic dissection ; pericarditis subacute bacterial endocarditis Patient 's refusal blood transfusion Oral anticoagulation therapy coumarin derivative within last 7 day Treatment UFH within 6 hour lowmolecular weight heparin within 8 hour randomization Treatment bivalirudin within 24 hour randomization Severe uncontrolled hypertension &gt; 180/110 mmHg unresponsive therapy Planned stag PCI procedure within 30 day index procedure prior PCI within last 30 day Relevant hematologic deviation : hemoglobin &lt; 100 g/L ; platelet count &lt; 100 x 109 /L Glomerular filtration rate ( GFR ) &lt; 30 ml/min serum creatinine &gt; 30 mg/L dependence renal dialysis Known allergy study medication : aspirin , clopidogrel , UFH , bivalirudin ; stainless steel ; true anaphylaxis prior exposure contrast medium Known heparininduced thrombocytopenia ( Typ II ) Previous enrollment trial Pregnancy ( present , suspected plan ) positive pregnancy test Spinal , peridural epidural anesthesia Patient 's inability fully cooperate study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>coronary disease</keyword>
</DOC>